The sales are consistent with routine option exercises and diversification rather than coordinated negative sentiment. The dollar amount is trivial relative to company size. No immediate trading signal; monitor for recurrence or larger-scale exits.
Price Chart
Executive Summary
Four insiders at United Therapeutics sold a combined $1.18 million in stock over a one-week window, including notable open-market sales by the CEO, CFO, general counsel, and a director. The transactions follow a pattern of routine option exercises and tax-related disposals, with the largest sale coming from a director.
Key Financial Metrics
Key Facts
- CEO Martine Rothblatt sold 65 shares for $36K on 2026-04-02 and gifted 698,384 shares in non-cash transactions on 2026-04-01
- CFO James Edgemon sold 120 shares for $66K and exercised options for 10,000 shares at $135.42
- General Counsel Paul Mahon sold 514 shares for $288K and exercised options for 8,300 shares at $146.03
- Director Christopher Causey sold 1,300 shares for $786K on 2026-03-30 at $604.64 per share
- Total open-market sales amounted to $1.18 million, representing less than 0.005% of the $24.5B market cap
Financial Impact
$1.18 million in open-market sales over 7 days, <0.005% of market cap
Risk Factors
- Perception of insider selling could weigh on sentiment short-term
- Potential misinterpretation of gift transactions as economic dispositions
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-UTHR-1775594183032 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | Insider Cluster | $500.35 $497.31 | ▼ −0.61% | ▼ −2.72% | $571.38 (+14.20%) |
Sep 11, 2026 21d ago | Insider Cluster | $497.11 $494.63 | ▼ −0.50% | ▼ −0.28% | $571.38 (+14.94%) |
Sep 10, 2026 22d ago | Insider Cluster | $503.86 $497.27 | ▼ −1.31% | ▼ −0.81% | $571.38 (+13.40%) |
Sep 9, 2026 23d ago | Insider Cluster | $506.82 $498.48 | ▼ −1.65% | ▼ −0.99% | $571.38 (+12.74%) |
Sep 4, 2026 28d ago | Insider Cluster | $487.61 $502.70 | ▲ +3.09% | ▲ +4.30% | $571.38 (+17.18%) |
Sep 3, 2026 29d ago | Insider Cluster | $488.16 $497.11 | ▲ +1.83% | ▲ +2.98% | $571.38 (+17.05%) |
Aug 28, 2026 5w ago | Insider Cluster | $515.46 $487.61 | ▼ −5.40% | ▼ −5.51% | $571.38 (+10.85%) |
Aug 27, 2026 5w ago | Insider Cluster | $527.91 $492.02 | ▼ −6.80% | ▼ −6.03% | $571.38 (+8.23%) |
Aug 26, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $571.38 (+10.59%) |
Aug 25, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $571.38 (+10.59%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access